— Know what they know.
Not Investment Advice

GNFTF OTC

Genfit S.a.
1W: +0.0% 1M: +0.0% 3M: +46.5% YTD: +162.5% 1Y: +323.4% 3Y: -1.9% 5Y: -52.4%
$15.75
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 49 · $789.0M mcap · 41M float · 0.0001% daily turnover · Short 93% of daily vol

Cash Flow Trends

Operating Cash Flow
$16M +127.4% ▲
Capital Expenditures
$979K +60.7% ▲
5Y CAGR: -13.6%
Free Cash Flow
$14M +124.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$4M +106.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$101M$67M-$24M-$29M$2M
Depreciation & Amort.$4M$3M$2M$2M$2M
Stock-Based Comp.$1M$470K$245K$578K$0
Change in Working Capital-$11M$60M-$55M-$28M$8M
Other Non-Cash Items$12M-$32M$4M-$1M$4M
Operating Cash Flow-$96M$100M-$73M-$55M$16M
— Investing Activities —
Capital Expenditures-$900K-$537K$0-$2M-$979K
Acquisitions (Net)$0$309K-$42M$0$0
Investment Purchases-$66K-$3M-$5M-$12K-$140K
Investment Sales$0-$309K$0$5M$0
Other Investing$0$308K$271K$172K$80K
Investing Cash Flow-$966K-$3M-$46M$2M-$1M
— Financing Activities —
Net Debt Issuance-$2M-$35M-$2M-$5M-$9M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$6M-$2M-$2M-$493K-$1M
Financing Cash Flow-$8M-$9M-$4M-$5M-$11M
Net Change in Cash-$106M$88M-$123M-$58M$4M
Cash End of Period$171M$259M$136M$78M$82M
Free Cash Flow-$97M$99M-$73M-$58M$14M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms